Sinalbin Potassium Salt extrapurified
Sinalbin Potassium Salt extrapurified
 Phthalimide potassium salt |
|
abx185537-500g |
Abbexa |
500 g |
EUR 258 |
|
|
) Clavulanate (potassium salt) |
|
C4271-25 |
ApexBio |
25 mg |
EUR 122 |
|
Description: Clavulanate is a metabolite existed in cultures of Streptomyces clavuligerusa with activity against both Gram-positive and Gram-negative bacteria. Clavulanate is a first clinically useful broad-spectrum ?-lactamase inhibitor. |
Clavulanate (potassium salt) |
|
C4271-50 |
ApexBio |
50 mg |
EUR 147 |
|
Description: Clavulanate is a metabolite existed in cultures of Streptomyces clavuligerusa with activity against both Gram-positive and Gram-negative bacteria. Clavulanate is a first clinically useful broad-spectrum ?-lactamase inhibitor. |
 Phosphoenolpyruvate potassium salt |
|
Q-1640.0005 |
Bachem |
5.0g |
EUR 273 |
|
Description: Sum Formula: C3H4KO6P; CAS# [4265-07-0] |
Phosphoenolpyruvate potassium salt |
|
Q-1640.0025 |
Bachem |
25.0g |
EUR 998 |
|
Description: Sum Formula: C3H4KO6P; CAS# [4265-07-0] |
 Raltegravir potassium salt |
|
B4760-10 |
ApexBio |
10 mg |
EUR 321 |
|
Description: Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection. |
Raltegravir potassium salt |
|
B4760-5 |
ApexBio |
5 mg |
EUR 199 |
|
Description: Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection. |
Raltegravir potassium salt |
|
B4760-50 |
ApexBio |
50 mg |
EUR 946 |
|
Description: Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection. |
) Piriprost (potassium salt) |
|
C4828-10 |
ApexBio |
10 mg |
EUR 506 |
|
Description: Piriprost (U 60257) is a leukotriene synthesis inhibitor [1].Leukotrienes belong to a family of eicosanoid inflammatory mediators produced in leukocytes. Leukotrienes mainly act on a subfamily of G protein-coupled receptors. |
Piriprost (potassium salt) |
|
C4828-5 |
ApexBio |
5 mg |
EUR 308 |
|
Description: Piriprost (U 60257) is a leukotriene synthesis inhibitor [1].Leukotrienes belong to a family of eicosanoid inflammatory mediators produced in leukocytes. Leukotrienes mainly act on a subfamily of G protein-coupled receptors. |
Piriprost (potassium salt) |
|
C4828-50 |
ApexBio |
50 mg |
EUR 2048 |
|
Description: Piriprost (U 60257) is a leukotriene synthesis inhibitor [1].Leukotrienes belong to a family of eicosanoid inflammatory mediators produced in leukocytes. Leukotrienes mainly act on a subfamily of G protein-coupled receptors. |
 Carboxyatractyloside Potassium Salt |
|
TBW00016 |
ChemNorm |
20mg |
EUR 484 |
 Atractyloside potassium salt |
|
TBW00062 |
ChemNorm |
20mg |
EUR 355 |
 Atractyloside Potassium salt |
|
B2441-1000 |
Biovision |
|
EUR 251 |
Atractyloside Potassium salt |
|
B2441-500 |
Biovision |
|
EUR 185 |
 Carboxyatractyloside Potassium salt |
|
B2442-1000 |
Biovision |
|
EUR 262 |
Carboxyatractyloside Potassium salt |
|
B2442-250 |
Biovision |
|
EUR 142 |
Phosphoenolpyruvate potassium salt |
|
B2674-1000 |
Biovision |
1000mg |
EUR 227 |
Phosphoenolpyruvate potassium salt |
|
B2674-250 |
Biovision |
250mg |
EUR 136 |
 Cyanine 5 potassium salt [equivalent to Cy5® potassium salt] |
|
255 |
AAT Bioquest |
5 mg |
EUR 219 |
|
|
 Fura Red, potassium salt |
|
21047 |
AAT Bioquest |
10x50 ug |
EUR 263 |
|
|
 Oxonic acid, potassium salt |
|
OD1239 |
Bio Basic |
5g |
EUR 70.88 |
|
|
 D-Luciferin, Potassium Salt |
|
D0510-010 |
GenDepot |
100mg |
EUR 185 |
D-Luciferin, Potassium Salt |
|
D0510-050 |
GenDepot |
500mg |
EUR 504 |
D-Luciferin, Potassium Salt |
|
D0510-100 |
GenDepot |
1g |
EUR 847 |
 Oxonic acid potassium salt |
|
20-abx184808 |
Abbexa |
-
EUR 509.00
-
EUR 314.00
-
EUR 230.00
|
|
|
|
 D-Luciferin, potassium salt |
|
10101 |
Biotium |
10MG |
EUR 112 |
|
Description: Minimum order quantity: 1 unit of 10MG |
D-Luciferin, potassium salt |
|
10101-1 |
Biotium |
50MG |
EUR 234 |
|
Description: Minimum order quantity: 1 unit of 50MG |
D-Luciferin, potassium salt |
|
10101-2 |
Biotium |
1G |
EUR 714 |
|
Description: Minimum order quantity: 1 unit of 1G |
 Carboxy-PTIO, potassium salt |
|
B6445-10 |
ApexBio |
10 mg |
EUR 137 |
Carboxy-PTIO, potassium salt |
|
B6445-100 |
ApexBio |
100 mg |
EUR 693 |
Carboxy-PTIO, potassium salt |
|
B6445-50 |
ApexBio |
50 mg |
EUR 416 |
 RU 28318, potassium salt |
|
B6822-10 |
ApexBio |
10 mg |
EUR 383 |
RU 28318, potassium salt |
|
B6822-50 |
ApexBio |
50 mg |
EUR 1455 |
Oxonic acid potassium salt |
|
B1154-5000 |
ApexBio |
5 g |
EUR 108 |
|
Description: Oxonic acid potassium salt is an inhibitor of uricase, oxonic inhibits the phosphorylation of 5-FU to 5-fluorouridine-5'-monophosphate catalyzed by pyrimidine phosphoribosyl-transferase in a different manner from allopurinol in cell-free extracts and inta |
 MK-5172 potassium salt |
|
A3620-10 |
ApexBio |
10 mg |
EUR 303 |
|
Description: IC50 Value: 7.4nM and 7nM for genotype1b and 1a respectively, in replicon system [1]MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development. |
MK-5172 potassium salt |
|
A3620-100 |
ApexBio |
100 mg |
EUR 1225 |
|
Description: IC50 Value: 7.4nM and 7nM for genotype1b and 1a respectively, in replicon system [1]MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development. |
MK-5172 potassium salt |
|
A3620-5 |
ApexBio |
5 mg |
EUR 212 |
|
Description: IC50 Value: 7.4nM and 7nM for genotype1b and 1a respectively, in replicon system [1]MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development. |
MK-5172 potassium salt |
|
A3620-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 274 |
|
Description: IC50 Value: 7.4nM and 7nM for genotype1b and 1a respectively, in replicon system [1]MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development. |
MK-5172 potassium salt |
|
A3620-50 |
ApexBio |
50 mg |
EUR 864 |
|
Description: IC50 Value: 7.4nM and 7nM for genotype1b and 1a respectively, in replicon system [1]MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development. |
D-Luciferin, Potassium Salt |
|
7903-100 |
Biovision |
|
EUR 120 |
D-Luciferin, Potassium Salt |
|
7903-10G |
Biovision |
|
EUR 2409 |
D-Luciferin, Potassium Salt |
|
7903-10PK |
Biovision |
|
EUR 2763 |
D-Luciferin, Potassium Salt |
|
7903-1G |
Biovision |
|
EUR 354 |
D-Luciferin, Potassium Salt |
|
7903-25G |
Biovision |
|
Ask for price |
D-Luciferin, Potassium Salt |
|
7903-3PK |
Biovision |
|
EUR 925 |
D-Luciferin, Potassium Salt |
|
7903-50G |
Biovision |
|
Ask for price |
D-Luciferin, Potassium Salt |
|
7903-5PK |
Biovision |
|
EUR 1496 |
 Okadaic acid, Potassium Salt |
|
1765-025 |
Biovision |
|
EUR 164 |
Okadaic acid, Potassium Salt |
|
1765-100 |
Biovision |
|
EUR 327 |
 Mag-Fluo-4 potassium salt |
|
20400 |
AAT Bioquest |
10x50 ug |
EUR 176 |
|
|
 Cal-500™, potassium salt |
|
20410 |
AAT Bioquest |
10x50 ug |
EUR 219 |
|
|
 Cal-670™, potassium salt |
|
20455 |
AAT Bioquest |
10x50 ug |
EUR 393 |
|
|
 Cal-770™, potassium salt |
|
20460 |
AAT Bioquest |
10x50 ug |
EUR 393 |
|
|
 Calbryte™-520L, potassium salt |
|
20642 |
AAT Bioquest |
10X50 ug |
EUR 306 |
|
|
 Calbryte™-520XL, potassium salt |
|
20645 |
AAT Bioquest |
10x50 ug |
EUR 306 |
|
|
 Calbryte™ 520, potassium salt |
|
20656 |
AAT Bioquest |
2x50 ug |
EUR 219 |
|
|
Calbryte™ 520, potassium salt |
|
20658 |
AAT Bioquest |
10x50 ug |
EUR 393 |
|
|
 Calbryte™ 590, potassium salt |
|
20706 |
AAT Bioquest |
5x50 ug |
EUR 306 |
|
|
Calbryte™ 590, potassium salt |
|
20707 |
AAT Bioquest |
1 mg |
EUR 702 |
|
|
 Calbryte™ 630, potassium salt |
|
20727 |
AAT Bioquest |
5x50 ug |
EUR 306 |
|
|
 Fluo-8L™, potassium salt |
|
21100 |
AAT Bioquest |
10x50 ug |
EUR 219 |
|
|
 Fluo-8FF™, potassium salt |
|
21102 |
AAT Bioquest |
10x50 ug |
EUR 219 |
|
|
 Cal-520®, potassium salt |
|
21140 |
AAT Bioquest |
10x50 ug |
EUR 306 |
|
|
Sinalbin Potassium Salt extrapurified
